Update on Mechanisms of Ischemic Acute Kidney Injury
The DOI matches its Crossref record; 209 of the 209 references it cites were found in a registry or an index.
Abstract
Acute renal failure (ARF), classically defined as an abrupt decrease in kidney function that leads to accumulation of nitrogenous wastes such as blood urea nitrogen and creatinine, is a common clinical problem with increasing incidence, serious consequences, unsatisfactory therapeutic options, and an enormous financial burden to society (1–5). ARF may be classified as prerenal (functional response of structurally normal kidneys to hypoperfusion), intrinsic renal (involving structural damage to the renal parenchyma), and postrenal (urinary tract obstruction). This review focuses on intrinsic ARF, which has emerged as the most common and serious subtype in hospitalized patients and can be associated pathologically with acute tubular necrosis (ATN). Consequently, it still is common clinical practice to use the terms intrinsic ARF and ATN interchangeably. Despite decades of pioneering basic research and important technical advances in clinical care, the prognosis for patients with intrinsic ARF remains poor, with a mortality rate of 40 to 80% in the intensive care setting. Two major problems have plagued the field and hindered progress. First, well over 20 definitions for ARF have been used in published studies, ranging from dialysis requirement to subtle increases in serum creatinine (6). In an attempt to standardize the definition and reflect the entire spectrum of the condition, the term acute kidney injury (AKI) has been proposed (4). AKI refers to a complex disorder that comprises multiple causative factors and occurs in a variety of settings with varied clinical manifestations that range from a minimal but sustained elevation in serum creatinine to anuric renal failure. Prerenal azotemia and other fully reversible causes of acute renal insufficiency are specifically excluded from the spectrum of AKI. An inherent shortcoming of this term is the continued reliance on serum creatinine measurements, and the definition of AKI undoubtedly will undergo enhancements as novel early biomarkers for the identification of ARF before the rise in serum creatinine come to light (7). This review avoids the term ATN and uses the expressions AKI and intrinsic ARF transposably. The second problem is an incomplete understanding of the cellular and molecular mechanisms that underlie AKI. This review updates the reader on current advances in basic and translational research that hold promise in human ischemic AKI. Classic concepts are mentioned briefly as founding principles but expanded on only if contemporary findings substantiate or refute them. The reader is referred to recent publications that address the mechanisms that underlie other causes of intrinsic AKI, such as sepsis (8) and nephrotoxins (9). However, from the clinical viewpoint, it is acknowledged that AKI is frequently multifactorial, with concomitant ischemic, nephrotoxic, and septic components and with overlapping pathogenetic mechanisms. Alterations in Morphology If function depends on form, then it follows that mechanisms that are invoked to elucidate kidney dysfunction in AKI also must explain the morphologic alterations. In this regard, the term ATN is a misnomer, because frank tubule cell necrosis is rarely encountered in human ARF. This fact has once again been driven home by careful examination of protocol kidney biopsies that are obtained soon after deceased-donor transplantation (10), which represents a predictable model for ischemic AKI (11). Prominent morphologic features of ischemic AKI in humans include effacement and loss of proximal tubule brush border, patchy loss of tubule cells, focal areas of proximal tubular dilation and distal tubular casts, and areas of cellular regeneration (12). Necrosis is inconspicuous and restricted to the highly susceptible outer medullary regions. The glomeruli are usually unimpressive, unless a primary glomerular disease had caused the ARF. This apparent disparity between the severe impairment of renal function and the relatively subtle histologic changes in AKI traditionally has been bothersome. More recently, however, reconciliation has been forthcoming from a consistent finding of apoptotic cell death in both distal and proximal tubules in both ischemic and nephrotoxic forms of human AKI (9,10). In addition, a great deal of attention has been directed toward the peritubular capillaries, which display a striking vascular congestion, endothelial damage, and leukocyte accumulation (13–15). The mechanisms that underlie these newly emphasized morphologic findings and their implications for the ensuing profound renal dysfunction are detailed herein. Alterations in Hemodynamics An intense and persistent renal vasoconstriction that reduces overall kidney blood flow to approximately 50% of normal has long been considered a hallmark of intrinsic ARF, prompting the previous designation of “vasomotor nephropathy” (1). As if to add insult to injury, the postischemic kidney also displays peculiar regional alterations in blood
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Because of this multifaceted protective action, NGAL has emerged as a prime therapeutic target in ischaemic AKI [379].”
In the citing paper
“The finding that NGAL was one of the most highly expressed proteins following ischaemia-reperfusion injury in kidney cells [372-374], and prognostic of kidney damage long before the more traditional marker creatinine was raised significantly, has led to considerable interest in this protein, especially as a marker of renal injury [375-389]”
Citations
Cites
Uchino, S. (2005) · JAMA · doi:10.1001/jama.294.7.813 · Cited by 4,176
Acute Kidney Injury, Mortality, Length of Stay, and Costs in Hospitalized Patients
Chertow, G. M., Burdick, E., Honour, M., Bonventre, J. V., & Bates, D. W. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004090740 · Cited by 3,408
Mishra, J., Dent, C., Tarabishi, R., Mitsnefes, M. M., Ma, Q., Kelly, C., Ruff, S. M., Zahedi, K., Shao, M., Bean, J., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)74811-x · Cited by 2,394 · cited 1×
“protein is markedly upregulated in kidney tubules very early after ischemic AKI in animals (38) and humans (190) and is rapidly excreted in the urine, where it represents a novel, sensitive, early biomarker of ischemic AKI (38,191).”
Self-citationKidney Injury Molecule-1 (KIM-1): A novel biomarker for human renal proximal tubule injury
Han, W. K., Bailly, V., Abichandani, R., Thadhani, R., & Bonventre, J. V. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00433.x · Cited by 1,929 · cited 1×
“cal membranes of proximal tubule epithelial cells, where it may play a role in renal regeneration (187,188).”
BackgroundMishra, J., Ma, Q., Prada, A., Mitsnefes, M., Zahedi, K., Yang, J., Barasch, J., & Devarajan, P. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000088027.54400.c6 · Cited by 1,749
Self-citationIchimura, T., Bonventre, J. V., Bailly, V., Wei, H., Hession, C. A., Cate, R. L., & Sanicola, M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.7.4135 · Cited by 1,265 · cited 4×
“KIM-1 protein subsequently was demonstrated to be upregulated in postischemic animal and human kidney tubules, predominantly on the apical membranes of proximal tubule epithelial cells, where it may play a role in renal regeneration (187,188).”
MethodInfluentialAcute Renal Failure and Sepsis
Schrier, R. W., & Wang, W. (2004) · New England Journal of Medicine · doi:10.1056/nejmra032401 · Cited by 1,260
Tögel, F., Hu, Z., Weiss, K., Isaac, J., Lange, C., & Westenfelder, C. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00007.2005 · Cited by 1,178 · cited 1×
“Fourth, the mode of protection by exogenously administered MSC may be related not to transdifferentiation processes but rather to powerful anti-inflammatory and antiapoptotic mechanisms that are being uncovered (117,124,125).”
BackgroundROLE OF C5A IN INFLAMMATORY RESPONSES
Guo, R.-F., & Ward, P. A. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115835 · Cited by 1,021
Delayed graft function in kidney transplantation
Perico, N., Cattaneo, D., Sayegh, M. H., & Remuzzi, G. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17406-0 · Cited by 972 · cited 1×
“This fact has once again been driven home by careful examination of protocol kidney biopsies that are obtained soon after deceased-donor transplantation (10), which represents a predictable model for ischemic AKI (11).”
Background
Cited by
Items 401–500 of 1,000
Sutton, T. A., Wilkinson, J., Mang, H. E., Knipe, N. L., Plotkin, Z., Hosein, M., Zak, K., Wittenborn, J., & Dagher, P. C. (2008) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.90304.2008 · Cited by 35
Han, S. J., Kim, J.-H., Kim, J. I., & Park, K. M. (2016) · Scientific Reports · doi:10.1038/srep27775 · Cited by 34
Expression of Kidney Injury Molecule-1 in Healthy and Diseased Feline Kidney Tissue
Bland, S., Schmiedt, C. W., Clark, M. E., DeLay, J., & Bienzle, D. (2017) · Veterinary Pathology · doi:10.1177/0300985817690213 · Cited by 33
“In other models of AKI, sublethal I/R initially causes S3 cellular depletion of ATP, leading to alteration in the apical actin cytoskeleton and microvillar rearrangement, which then leads to the formation of membrane-bound extracellular vesicles or cytoplasmic blebs.(26,78,80,83) These blebs are shed into the lumen an…”
BackgroundRomero, A. J. A., Gil-Ruiz, M. A., Castillo, A., López, J., Romero, C., Fernández, S. N., & Carrillo, Á. (2013) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0000000000000034 · Cited by 32
“The identification of these children in the start-up phase of AKI development, which in our case represents the first postoperative hours (18, 33), will permit us implement preventive measures against the progression of the renal failure and improve the patients’ outcome.”
Protective roles of bioactive peptides during ischemia-reperfusion injury: From bench to bedside
Wu, D., Wang, J., Wang, H., Ji, A., & Li, Y. (2017) · Life Sciences · doi:10.1016/j.lfs.2017.05.014 · Cited by 32
“The pathogenetic mechanisms underlying renal I/R injury involve a number of factors, such as hypoxia, production of ROS, inflammatory reaction, vascular endothelial injury, and the renin-angiotensin system [70,71].”
BackgroundZhang, J., Zhao, D., Na, N., Li, H., Miao, B., Hong, L., & Huang, Z. (2017) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2017.3204 · Cited by 35
Lee, J., Song, S. H., Lee, J. Y., Kim, D. G., Lee, J. G., Kim, B. S., Kim, M. S., & Huh, K. H. (2017) · Scientific Reports · doi:10.1038/s41598-017-14154-w · Cited by 33
Moloudizargari, M., Govahi, A., Fallah, M., Rezvanfar, M. A., Asghari, M. H., & Abdollahi, M. R. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.30038 · Cited by 34
“Renal ischemia–reperfusion injury is an inflammatory disorder, known as the main cause of acute kidney injury (Devarajan, 2006).”
BackgroundHess, H. W., Stooks, J., Baker, T. B., Chapman, C. L., Johnson, B. D., Pryor, R. R., Basile, D. P., Monroe, J. C., Hostler, D. P., & Schlader, Z. J. (2022) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00601.2021 · Cited by 36
Interleukin-19 Mediates Tissue Damage in Murine Ischemic Acute Kidney Injury
Hsu, Y., Li, H.-H., Sung, J., Chen, W.-T., Hou, Y., & Chang, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056028 · Cited by 32
“Injured tubular epithelial cells generate a number of mediators that potentiate the inflammatory response, such as proinflammatory cytokines (TGF-b1, TNF-a, IL-6, and IL-1b) and chemotactic cytokines (MCP-1, CXCL10, and RANTES) [4,18].”
BackgroundUNC5B Receptor Deletion Exacerbates Tissue Injury in Response to AKI
Ranganathan, P. V., Jayakumar, C., Navankasattusas, S., Li, D. Y., Kim, I., & Ramesh, G. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013040418 · Cited by 33
Progression of chronic kidney disease after acute kidney injury
Devarajan, P., & Jefferies, J. L. (2015) · Progress in Pediatric Cardiology · doi:10.1016/j.ppedcard.2015.12.006 · Cited by 39
“capacity for repair and regeneration after AKI [87–89].”
BackgroundSelf-citationPreconditioning mice with activators of AMPK ameliorates ischemic acute kidney injury in vivo
Lieberthal, W., Tang, M., Lusco, M. A., Abate, M. T., & Levine, J. S. (2016) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00541.2015 · Cited by 32
The early biomarker of acute kidney injury: in search of the Holy Grail
Honoré, P. M., Joannès-Boyau, O., & Boer, W. (2007) · Intensive Care Medicine · doi:10.1007/s00134-007-0766-0 · Cited by 32
“However, in the critical care community the similar development of an early marker for renal dysfunction remains elusive [4].”
BackgroundGarg, A. X., Marcucci, M., Cuerden, M. S., Sontrop, J. M., Painter, T. W., Lomivorotov, V. N., Sessler, D. I., Chan, M. T. V., Borges, F. K., Leslie, K., et al. (2024) · Kidney International · doi:10.1016/j.kint.2024.10.007 · Cited by 31
Yang, C., Hosgood, S. A., Patel, M. S., Long, Y., Zhu, T., Nicholson, M. L., & Yang, B. (2015) · Transplantation Direct · doi:10.1097/txd.0000000000000515 · Cited by 31
Patschan, D., Kribben, A., & Muller, G. A. (2016) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00232.2016 · Cited by 34
Zhang, J., Wang, X., Lu, G., Huang, H., & Xu, S. (2017) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12811 · Cited by 34
Lu, Z., Song, N., Shen, B., Xu, X., Fang, Y., Shi, Y., Ning, Y., Hu, J., Dai, Y., Ding, X., et al. (2018) · Transplantation · doi:10.1097/tp.0000000000002170 · Cited by 31
Sun, W., Choi, H. S., Kim, C. S., Bae, E. H., Kwon, S., & Kim, S. W. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.807452 · Cited by 41
“Cells trigger specific signaling pathways due to inflammation or oxidative stress to cause cell death (Devarajan, 2006).”
BackgroundBouchard, J., & Mehta, R. L. (2009) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2009.00561.x · Cited by 31
“Subsequent hypotension and hypoperfusion can cause new kidney lesions (13,14).”
Proteomic analysis of acute kidney injury: Biomarkers to mechanisms
BENNETT, M. R., & Devarajan, P. (2010) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201000066 · Cited by 33
“Over the past 50 years the prognosis of AKI has remained quite poor with a mortality rate of 40–80% in the intensive care setting [15, 16].”
BackgroundSelf-citationStroo, I., Stokman, G., Teske, G. J. D., Florquin, S., & Leemans, J. C. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp050 · Cited by 36
“Several studies have found Y-chromosome-positive TEC in renal female grafts transplanted into male recipients, and in kidneys of female mice transplanted with male bone marrow [3–5].”
BackgroundInfluentialUrinary Biomarkers for Early Detection of Recovery in Patients with Acute Kidney Injury
Moon, S. J., Park, H., Yoon, S. Y., & Lee, S. C. (2013) · Journal of Korean Medical Science · doi:10.3346/jkms.2013.28.8.1181 · Cited by 31
“However, these markers are of limited use for early detection of AKI (10, 11).”
BackgroundOxidized phosphatidylcholines are produced in renal ischemia reperfusion injury
Solati, Z., Edel, A. L., Shang, Y., Karmin, O., & Ravandi, A. (2018) · PLoS ONE · doi:10.1371/journal.pone.0195172 · Cited by 35
Neutrophil Gelatinase-Associated Lipocalin in Acute Kidney Injury
Makris, K., & Kafkas, N. V. (2012) · Advances in clinical chemistry · doi:10.1016/b978-0-12-394383-5.00012-6 · Cited by 36
The protective effects of silymarin on ischemia-reperfusion injuries: A mechanistic review.
Kordkheyli, V. A., Abbaszadeh‐Goudarzi, K., Nejati-Laskokalayeh, M., Zarpou, S., & Khonakdar-Tarsi, A. (2019) · PubMed Central · doi:10.22038/ijbms.2019.34284.8147 · Cited by 40
“In pre-acute phase, the lack of oxygen as the last acceptor of electron in the respiratory chain causes a decrease in ATP production and eventually leads to the disruption of membrane transport, acidosis, cellular edema and membrane distortion of organelles, and cells (1, 2).”
BackgroundWu, D., Chen, X., Ding, R., Qiao, X., Shi, S., Xie, Y., Hong, Q., & Feng, Z. (2008) · American Journal of Nephrology · doi:10.1159/000113107 · Cited by 30
“Many factors might contribute to this injury, such as calcium overload, inflammation, alterations in tubule cell structure or metabolism [”
BackgroundBβ15–42 Attenuates the Effect of Ischemia-Reperfusion Injury in Renal Transplantation
Sörensen, I., Rong, S., Susnik, N., Gueler, F., Shushakova, N., Albrecht, M., Dittrich, A., von Vietinghoff, S., Becker, J. U., Melk, A., et al. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011010031 · Cited by 30
Patschan, D., Schwarze, K., Henze, E., Patschan, S., & Müller, G. (2015) · JN. Journal of Nephrology (Milano. 1992) · doi:10.1007/s40620-015-0222-0 · Cited by 29
“The microenvironmental alterations associated with ischemia can significantly aggravate renal damage since ischemia does not only induce tubular malfunction/damage but also interstitial inflammation and severe microvasculopathy [8].”
BackgroundThe Future of Pediatric Acute Kidney Injury Management—Biomarkers
Devarajan, P. (2008) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2008.05.010 · Cited by 29
“5 In addition to early diagnosis, biomarkers ay serve several other purposes in AKI,6 such s (1) identifying the primary location of injury proximal tubule, distal tubule, interstitium, or asculature); (2) discerning AKI subtypes (preenal, intrinsic renal, or postrenal); (3) identifyng AKI etiologies (ischemia, toxins…”
BackgroundSelf-citationPérez-Meseguer, J., Torres-González, L., Gutiérrez-González, J. A., Alarcón-Galván, G., Zapata-Chavira, H. A., de Torres, N. H. W., Moreno-Pena, D. P., Muñoz-Espinosa, L. E., & Cordero‐Pérez, P. (2019) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-019-2604-7 · Cited by 29
Madjène, L. C., Danelli, L., Dahdah, A., Vibhushan, S., Bex-Coudrat, J., Pacreau, E., Vaugier, C., Claver, J., Rolas, L., Pons, M., et al. (2019) · Kidney International · doi:10.1016/j.kint.2019.08.037 · Cited by 29
Saeed, Z. M., Khattab, M. I., Khorshid, N. E., & Salem, A. E. (2022) · PLoS ONE · doi:10.1371/journal.pone.0271591 · Cited by 29
“AKI induced by cancer chemotherapeutic, such as cisplatin, alternatively, includes oxidative stress, proximal tubule cell death, and loss of the brush border membrane and polarity [3].”
Activin A: Autocrine Regulator of Kidney Development and Repair
Maeshima, A., Miya, M., Mishima, K., Yamashita, S., Kojima, I., & Nojima, Y. (2008) · Endocrine Journal · doi:10.1507/endocrj.kr-113 · Cited by 29
“Following proliferation, the new cells then differentiate to restore the functional integrity of nephrons [52, 53].”
BackgroundChen, G., Fu, Y., & Wu, X. (2012) · Molecules · doi:10.3390/molecules17021191 · Cited by 29
“ROS, which are produced during renal reperfusion, have diverse cytotoxic effects, including DNA damage, protein oxidation and nitrosylation, lipid peroxidation, and induction of apoptosis [4].”
BackgroundInfluentialThe Association of Preoperative Statin Use and Acute Kidney Injury After Noncardiac Surgery
ARGALIOUS, M. Y., Dalton, J. E., Sreenivasalu, T., O’Hara, J. F., & Sessler, D. I. (2013) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e31828175ab · Cited by 31
Li, N., Zhao, W., Xu, F.-L., Zhang, W., & Gu, W.-T. (2013) · Journal of Nephrology · doi:10.5301/jn.5000282 · Cited by 29
Shacham, Y., Leshem‐Rubinow, E., Gal‐Oz, A., Arbel, Y., Keren, G., Roth, A., & Steinvil, A. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2014.07.032 · Cited by 29
Mousavi, G. (2015) · Acta Cirúrgica Brasileira · doi:10.1590/s0102-865020150080000005 · Cited by 30
TRPM7 in CHBP-induced renoprotection upon ischemia reperfusion-related injury
Liu, A., Wu, J., Yang, C., Wu, Y., Zhang, Y., Zhao, F., Wang, H., Yuan, L., Song, L., Zhu, T., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-22852-2 · Cited by 29
“The mice were randomly divided into three groups (n = 6 for each time point): (1) sham group, mice were operated similarly without the renal pedicle clamping.”
MethodBoys, J. A., Toledo, A. H., Anaya‐Prado, R., López-Neblina, F., & Toledo-Pereyra, L. H. (2010) · Journal of Investigative Medicine · doi:10.2310/jim.0b013e3181e5d719 · Cited by 29
“Sites affected during renal IRI include proximal tubule brush border, distal and proximal tubule cells, and medullary regions.(43) The RyR2 isoform is found in kidney cells.”
BackgroundAtherosclerotic renovascular disease: beyond the renal artery stenosis
Meier, P., Rossert, J., Plouin, P., & Burnier, M. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfl784 · Cited by 33
“Mechanisms that underlie these haemodynamic alterations have begun to surface, and they relate primarily to endothelial cell injury [19].”
BackgroundMuroya, Y., Fan, F., Regner, K. R., Falck, J. R., Garrett, M. R., Juncos, L. A., & Roman, R. J. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014090868 · Cited by 28
Kumaş, M., Eşrefoğlu, M., Karataş, E., Duymaç, N., Kanbay, S., Ergün, İ. S., Üyüklü, M., & Koçyiğit, A. (2019) · Nefrología · doi:10.1016/j.nefro.2018.10.006 · Cited by 30
Xing, D., Ma, Y., Lu, M., Liu, W., & Zhou, H. (2023) · BMC Nephrology · doi:10.1186/s12882-023-03366-0 · Cited by 28
“Kidney proximal tubule epithelial cells play a key role in renal reabsorption, which requires high ATP levels [4].”
BackgroundFiliopoulos, V., Biblaki, D., & Vlassopoulos, D. (2014) · Renal Failure · doi:10.3109/0886022x.2014.900429 · Cited by 28
“In any case, plasma-based diagnostics have revolutionized many aspects of clinical medicine, as exemplified by the use of troponins for the early diagnosis of acute myocardial infarction and the value of B-type natriuretic peptide for prognostication in acute coronary syndromes.(5,6,34)”
BackgroundMethodResultInfluentialXiunan, J., Zhang, Y., Li, X., Zhang, J., & Xu, D. (2014) · Life Sciences · doi:10.1016/j.lfs.2014.09.023 · Cited by 28
Finge, T., Bertran, S., Roger, C., Candela, D., Pereira, B., Scott, C. G., Müller, L., Louart, B., & Lefrant, J. (2017) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000002116 · Cited by 27
Animal Models of Kidney Disease
Mohammed‐Ali, Z., Carlisle, R. E., Nademi, S., & Dickhout, J. G. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809468-6.00016-4 · Cited by 42
Ahmadvand, H., Babaeenezhad, E., Nasri, M., Jafaripour, L., & Khorramabadi, R. M. (2018) · Journal of Renal Injury Prevention · doi:10.15171/jrip.2019.18 · Cited by 27
“Nevertheless, it is mainly believed that the principle factors which make kidney injury during IR are reactive oxygen species (ROS) and reactive nitrogen species (RNS) (4).”
BackgroundThe Current State of the Art in Acute Kidney Injury
Devarajan, P. (2020) · Frontiers in Pediatrics · doi:10.3389/fped.2020.00070 · Cited by 30
“Despite promising pre-clinical data, the human AKI literature is littered with numerous disappointing treatment failures—including forced diuresis and RGD peptides for tubular obstruction, ATP donors (ATP-Mg, thyroxine) for intracellular ATP depletion, natriuretic peptides and dopamine for vasoconstriction, reactive o…”
BackgroundSelf-citationStem Cells and Their Role in Renal Ischaemia Reperfusion Injury
Bagul, A. A., Frost, J. H., & Drage, M. W. (2012) · American Journal of Nephrology · doi:10.1159/000345731 · Cited by 27
The Antioxidant EPC-K1 Attenuates Renal Ischemia-Reperfusion Injury in a Rat Model
Yamamoto, S., Hagiwara, S., Hidaka, S., Shingu, C., Goto, K., Kashima, K., & Noguchi, T. (2011) · American Journal of Nephrology · doi:10.1159/000327820 · Cited by 27
Serum Uric Acid Exhibits Inverse Relationship with Estimated Glomerular Filtration Rate
Koratala, A., Singhania, G., Alquadan, K. F., Shimada, M., Johnson, R. J., & Ejaz, A. A. (2016) · The Nephron journals/Nephron journals · doi:10.1159/000448629 · Cited by 27
Gebremichael, Y., Lu, J. J.-Q., Shankaran, H., Helmlinger, G., Mettetal, J. T., & Hallow, K. M. (2017) · Toxicological Sciences · doi:10.1093/toxsci/kfx239 · Cited by 29
Najafi, H., Owji, S. M., Kamali‐Sarvestani, E., & Moosavi, S. M. S. (2016) · Experimental Physiology · doi:10.1113/ep085583 · Cited by 26
“The renal I/R-induced tubular epithelial damage is either lethal, expressed as necrosis and apoptosis, or sublethal, including loss of tight junction integrity and cell polarity, shedding of brush borders and exfoliation of viable cells (Devarajan, 2006; Moosavi et al. 2009).”
BackgroundSepsis and AKI in Clinical Emergency Room Patients: The Role of Urinary NGAL
Nga, H. S., Medeiros, P., Menezes, P., Bridi, R. A., Balbi, A. L., & Ponce, D. (2015) · BioMed Research International · doi:10.1155/2015/413751 · Cited by 28
Nitric Oxide and its Metabolites in the Critical Phase of Illness: Rapid Biomarkers in the Making
Mian, A. I., Aranke, M., & Bryan, N. S. (2013) · The Open Biochemistry Journal · doi:10.2174/1874091x01307010024 · Cited by 31
Long-term sequelae of acute kidney injury in the ICU
Cohen, S. D., & Kimmel, P. L. (2012) · Current Opinion in Critical Care · doi:10.1097/mcc.0b013e328358d3f5 · Cited by 28
The road from AKI to CKD: the role of endothelin
Dhaun, N., & Webb, D. J. (2013) · Kidney International · doi:10.1038/ki.2013.158 · Cited by 26
Mining kidney toxicogenomic data by using gene co-expression modules
AbdulHameed, M. D. M., Ippolito, D. L., Stallings, J. D., & Wallqvist, A. (2016) · BMC Genomics · doi:10.1186/s12864-016-3143-y · Cited by 28
“…through a number of different biological processes, including the induction of apoptosis through Casp8 and Casp3 for nephrotoxic drugs [79], obstruction of tubular lumen by Fn1 [80], and dysregulation of cytosolic calcium levels linked to Anxa7 in connection with acute tubular necrosis [81 – 83].”
BackgroundPharmacological Inhibition of PTEN Aggravates Acute Kidney Injury
Zhou, J., Li, J., Hu, Z., & Wang, Y. (2017) · Scientific Reports · doi:10.1038/s41598-017-10336-8 · Cited by 26
“After washing, the beads were resuspended in PTEN reaction buffer and PTEN enzyme reaction was initiated by adding PI(3,4,5)P3 substrate for 1 hour at 37 °C.”
Yang, R., Liu, S., Wen, J., Xue, L., Zhang, Y., Yan, D., Wang, G., & Liu, Z. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27163 · Cited by 28
Liu, H., Wu, R., Jia, R., Zhong, B., Zhu, J., Peng, Y., Zhao, Y., Ge, Y., & Wu, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055389 · Cited by 27
“Renal IRI refers to a complex disorder that comprises multiple causative factors [32].”
BackgroundInduction of proapoptotic Daxx following ischemic acute kidney injury
Ma, Q., & Devarajan, P. (2008) · Kidney International · doi:10.1038/ki.2008.192 · Cited by 27
Self-citationPatschan, D., Rinneburger, J., Idrizi, N., Backhaus, R., Schwarze, K., Henze, E., Patschan, S. A., & Muller, G. A. (2013) · BMC Nephrology · doi:10.1186/1471-2369-14-227 · Cited by 25
“The most common cause is prolonged hypoperfusion (acute ischemic kidney injury – iAKI) [4].”
BackgroundMohammadzadeh-Vardin, M., Roudkenar, M. H., & Jahanian‐Najafabadi, A. (2015) · Advanced Pharmaceutical Bulletin · doi:10.15171/apb.2015.028 · Cited by 25
The Ste20-like kinase SLK promotes p53 transactivation and apoptosis
Cybulsky, A. V., Takano, T., Guillemette, J., Papillon, J., Volpini, R. A., & Battista, J. A. D. (2009) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00294.2009 · Cited by 26
“Interruption of renal blood flow leads to ischemia, a major cause of acute renal failure (11).”
BackgroundMagnetic susceptibility anisotropy outside the central nervous system
Dibb, R., Xie, L., Wei, H., & Liu, C. (2016) · NMR in Biomedicine · doi:10.1002/nbm.3544 · Cited by 27
Tai, Q., Yi, H., Wei, X., Xie, W., Zeng, O., Zheng, D., Sun, J., Wang, G., Wang, S., & Liu, G. (2018) · Journal of Intensive Care Medicine · doi:10.1177/0885066618807124 · Cited by 25
“As novel and promising biomarkers, TIMP-2 and IGFBP7 are inducers of G1 cell cycle arrest, which is considered a key mechanism of AKI.(38,39) After stress, injury, or cellular damage, renal tubular cells exhibit G1 cell cycle arrest for a short period, with TIMP2 and IGFBP7 playing critical roles until the damage has…”
BackgroundCardiopulmonary Bypass and AKI: AKI Is Bad, So Let's Get Beyond the Diagnosis
Krawczeski, C. D. (2019) · Frontiers in Pediatrics · doi:10.3389/fped.2019.00492 · Cited by 25
“During the extension phase, these pathways progress, resulting in apoptosis, cell membrane alterations, cytoskeletal degradation, and oxidant injury (11).”
BackgroundHuang, L., Zhang, R., Wu, J. C., Chen, J., Grosjean, F., Satlin, L. M., Klein, J. D., Sands, J. M., Striker, G. E., Tan, M. J., et al. (2010) · Kidney International · doi:10.1038/ki.2010.469 · Cited by 25
Lowering serum uric acid to prevent acute kidney injury
Ejaz, A. A., Dass, B., Kambhampati, G., Ejaz, N. I., Maroz, N., Dhatt, G. S., Arif, A. A., Faldu, C., Lanaspa, M. A., Shah, G., et al. (2012) · Medical Hypotheses · doi:10.1016/j.mehy.2012.03.011 · Cited by 25
“Ischemic AKI involves loss of renal blood flow autoregulation related to vasoconstrictors, hypoperfusion, ischemia/reperfusion injury and activation of the inflammatory cascade [6].”
Backgrounddos Santos, E. B., Koff, W. J., Filho, T. D. J. M. G., de Rossi, S. D., Treis, L., Bona, S., Pêgas, K. L., Katz, B., Meyer, F., Marroni, N. P., et al. (2013) · Acta Cirúrgica Brasileira · doi:10.1590/s0102-86502013000800003 · Cited by 24
Song, Y., Liu, W., Ding, Y., Jia, Y., Zhao, J., Wang, F., Bai, J., Cheng, L., Gao, K., Liu, M., et al. (2018) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00508.2017 · Cited by 24
“Tubular apoptosis is a crucial event in I/R-induced renal injury and drives the severity of tissue damage (6, 31).”
BackgroundCell-Based Therapies in Acute Kidney Injury (AKI)
Patschan, D., Buschmann, I. R., Ritter, O., & Kribben, A. (2018) · Kidney & Blood Pressure Research · doi:10.1159/000489624 · Cited by 24
Nielsen, P. M., Qi, H., Bertelsen, L. B., & Laustsen, C. (2020) · Scientific Reports · doi:10.1038/s41598-020-65816-1 · Cited by 24
Aoun, B., Daher, G. A., Daou, K. N., Sanjad, S. A., Tamim, H., Rassi, I. E., Arabi, M. T., Sharara-Chami, R. I., Bitar, F. F., Assy, J., et al. (2021) · Frontiers in Pediatrics · doi:10.3389/fped.2021.637463 · Cited by 25
“Several mechanisms for AKI post-cardiac surgery have been described, including renal ischemia and reperfusion injury, maladaptive inflammatory response, oxidative stress, microemboli, and alteration in tubular cell metabolism (10, 11).”
BackgroundSoyler, C., Tanrıöver, M. D., Aşçıoğlu, S., Aksu, N. M., & Arıcı, M. (2015) · Renal Failure · doi:10.3109/0886022x.2015.1033324 · Cited by 24
Assessing continuous renal replacement therapy as a rescue strategy in cardiorenal syndrome 1
Prins, K. W., Wille, K. M., Tallaj, J. A., & Tolwani, A. (2014) · Clinical Kidney Journal · doi:10.1093/ckj/sfu123 · Cited by 24
“Studies have shown that TNF-α and IL-6 are elevated in ADHF [15–18] and may play a role in AKI [19, 20].”
BackgroundPatschan, D., Schwarze, K., Henze, E., Patschan, S. A., & Muller, G. A. (2016) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00306.2015 · Cited by 24
“The present study offers new insights into the mechanistical interplay between eEPCs and mature endothelial cells in ischemic AKI: serum creatinine levels did not completely normalize until week 6 postischemia.”
BackgroundInfluentialKim, D.-J., Kang, J. M., Park, S. H., Kwon, H., Song, S.-J., Moon, H., Kim, S.-M., Seo, J.-W., Lee, Y. H., Kim, Y., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-16977-z · Cited by 25
Glutamine contributes to ameliorate inflammation after renal ischemia/reperfusion injury in rats
Esposito, E., Mondello, S., Paola, R. D., Mazzon, E., Italiano, D., Paterniti, I., Mondello, P., Aloisi, C., & Cuzzocrea, S. (2011) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-011-0610-5 · Cited by 24
“A multitude of pathways including the intrinsic (Bcl-2 family, cytochrome c, and caspase 9), extrinsic (Fas, FADD, and caspase 8), and regulatory (p53 and NF-κB) factors seem to be activated (Devarajan 2006).”
BackgroundLiu, X., Cai, J., Jiao, X., Yu, X., & Ding, X. (2017) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmx016 · Cited by 25
“AKI most commonly occurs after ischemia or nephrotoxic insult and carries a high risk of mortality [6,7].”
BackgroundCD4+lymphocyte adenosine triphosphate - a new marker in sepsis with acute kidney injury?
Patschan, D., Heeg, M. H. J., Brier, M., Brandhorst, G., Schneider, S., Muller, G. A., & Koziolek, M. J. (2014) · BMC Nephrology · doi:10.1186/1471-2369-15-203 · Cited by 24
“Among those are T and B cell, monocytes/macrophages, dendritic cells, granulocytes, and plasma cells [5].”
BackgroundInfluentialShiravi, A., Jalili, C., Vaezi, G., Ghanbari, A., & Alvani, A. (2020) · International Journal of Preventive Medicine · doi:10.4103/ijpvm.ijpvm_512_18 · Cited by 23
“The renal ischemia‐reperfusion‐induced tubular epithelial damage is either lethal, expressed as necrosis and apoptosis, or sub‐lethal, including loss of tight junction integrity and cell polarity, shedding of brush borders and exfoliation of viable cells.[19,20] In the present study, the percentage of apoptotic cells…”
ResultLeballo, G., & Chakane, P. M. (2020) · Cardiovascular journal of South Africa/Cardiovascular journal of Southern Africa · doi:10.5830/cvja-2019-069 · Cited by 25
“This promotes the cascade of an inflammatory response.(18) Pro-inflammatory cytokines such as tumour necrosis factor-alpha (TNF-α), interleukins 6 and 8 (IL-6, IL-8) and chemotactic cytokines have been implicated in contributing to the response of local tissue ischaemia that results in maladaptive inflammatory tissue…”
BackgroundHusain‐Syed, F., Emlet, D. R., Wilhelm, J., Danesi, T. H., Ferrari, F., Bezerra, P., López-Giacoman, S. R., Villa, G., Tello, K., Birk, H., et al. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03410-x · Cited by 25
“Mechanistically, TIMP-2 and IGFBP7 are two independent proteins that are released in response to proximal and distal tubular insults and are thought to be engaged in self-protective mechanisms such as AKIinduced transient cell cycle arrest [37, 39, 40].”
BackgroundCybulsky, A. V., Takano, T., Papillon, J., Guillemette, J., Herzenberg, A. M., & Kennedy, C. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.100263 · Cited by 28
“Thus, SLK is a renal epithelial protein kinase, whose expression and activity are increased during development, and recovery from acute renal failure, where injured tubular epithelial cells may regenerate by recapitulating developmental processes.(8) Moreover, expres-”
BackgroundActivity of the Ste20-like kinase, SLK, is enhanced by homodimerization
Delarosa, S., Guillemette, J., Papillon, J., Han, Y.-S., Kristof, A. S., & Cybulsky, A. V. (2011) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00062.2011 · Cited by 33
Protective Effect of Peptide GV1001 Against Renal Ischemia-Reperfusion Injury in Mice
Koo, T. Y., Yan, J.-J., & Yang, J. (2014) · Transplantation Proceedings · doi:10.1016/j.transproceed.2013.12.019 · Cited by 23
L-FABP can be an early marker of acute kidney injury in children
Ivanišević, I., Peco‐Antić, A., Vuličević, I., Hercog, Ð., Milovanović, V., Kotur‐Stevuljević, J., Stefanović, A., & Kocev, N. I. (2013) · Pediatric Nephrology · doi:10.1007/s00467-013-2421-z · Cited by 23
“Because uL-FABP is expressed predominantly in proximal tubules, in the nephron segment with very high energy requirements, its urinary excretion increases in accordance with the ischemic state after CPB [29, 30].”
Cytochrome c: potential as a noninvasive biomarker of drug-induced acute kidney injury
Small, D. M., & Gobe, G. C. (2012) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2012.679657 · Cited by 23
“Intrinsic ARF occurs in response to cytotoxic, ischemic or inflammatory injury to the kidney, sometimes with extensive structural and functional damage [12,13].”
BackgroundToll-Like Receptor as a Potential Biomarker in Renal Diseases
Mertowski, S., Lipa, P., Morawska, I., Niedźwiedzka‐Rystwej, P., Bębnowska, D., Hrynkiewicz, R., Grywalska, E., Roliński, J., & Załuska, W. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186712 · Cited by 24
Kim, H. J., Kim, S., Kim, M., Baik, H., Park, S. J., Kang, M. S., Kim, D., Kim, B. W., Markowitz, S. D., & Bae, K. B. (2020) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00103.2020 · Cited by 26
Vogelaar, P. C., Roorda, M., de Vrij, E. L., Houwertjes, M. C., Goris, M., Bouma, H. R., van der Graaf, A. C., Krenning, G., & Henning, R. H. (2018) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfy080 · Cited by 24
Zhang, G., Yang, Y.-C., Huang, Y., Zhang, L., Ling, Z., Zhu, Y., Wang, F., Zou, X., & Chen, M. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.03.096 · Cited by 22
Carnosol protects against renal ischemia-reperfusion injury in rats
Zheng, Y., Zhang, Y., Zheng, Y., & Zhang, N. (2018) · EXPERIMENTAL ANIMALS · doi:10.1538/expanim.18-0067 · Cited by 24
“Reports have shown that apoptosis is one of the most important mechanisms of renal IRI [4, 6].”
BackgroundInfluentialPrognosis of AKI in malignant diseases with and without sepsis
Heeg, M. H. J., Mertens, A., Ellenberger, D., Muller, G. A., & Patschan, D. (2013) · BMC Anesthesiology · doi:10.1186/1471-2253-13-36 · Cited by 22
“Prognosis has not substantially been improved during the last 20–30 years since mortality rates still vary between 30-50% [3].”
Background
Metadata
- Authors
- Devarajan, P.
- Affiliations
- Cincinnati Children's Hospital Medical Center (US)
- Corresponding author
- Devarajan, Prasad
- ORCID
- Devarajan, Prasad
- Venue
- Journal of the American Society of Nephrology
- Published
- 2006-06
- Volume
- 17
- Issue
- 6
- Pages
- 1503-1520
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2164965999
- Cited by
- 1,026
- References
- 209
- Citations by year
- 2026: 16 · 2025: 22 · 2024: 45 · 2023: 38 · 2022: 39 · 2021: 43 · 2020: 56 · 2019: 53 · 2018: 56 · 2017: 55 · 2016: 82 · 2015: 87 · 2014: 74 · 2013: 64 · 2012: 62
- FWCI
- 26.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of the American Society of Nephrology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Heart Association
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (P50 DK 52612, R21DK070163, R01-DK53289, P50DK052612, R01DK053289)
- Topics
- Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Nephrology › Nephrotoxicity and Medicinal Plants
- Keywords
- acute kidney injury, ischemic acute kidney injury, acute tubular necrosis, renal tubular epithelial cells, tubular epithelial cell proliferation, renal tubular regeneration, renal hypoxia, renal ischemia-reperfusion injury, AKI pathogenesis, kidney injury biomarkers, AKI definitions, serum creatinine limitations
- MeSH terms
- Acute Disease, Adenosine Triphosphate, Animals, Calcium, Humans, Ischemia, Kidney, Kidney Tubules, Models, Biological, Regional Blood Flow, Reactive Oxygen Species, Renal Insufficiency
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.